Antihypertensive Avoidance in Diabetes

The patient is a 52-year-old diabetic presenting with recurrent hypoglycemia and hypertension (BP: 160/100 mm Hg). The key concern is selecting an antihypertensive that does not exacerbate or mask hypoglycemia symptoms.

Why Propranolol Should Be Avoided

• Propranolol is a non-selective beta-blocker.
• Beta-blockers can inhibit the body's natural response to low blood sugar (hypoglycemia), such as increased heart rate and tremors. This masking effect can delay the recognition and treatment of hypoglycemia.
• They may also potentially prolong hypoglycemic episodes by interfering with glucose production (gluconeogenesis and glycogenolysis).
• Given the patient's history of recurrent hypoglycemia, using a beta-blocker like Propranolol is contraindicated due to the risk of masking symptoms and worsening glycemic control.

Other Antihypertensive Options

• Telmisartan: An angiotensin II receptor blocker (ARB), generally considered safe in diabetics and does not typically mask hypoglycemia.
• Torsemide: A loop diuretic. While diuretics can affect electrolytes and glucose metabolism, they don't primarily mask hypoglycemia symptoms.
• Amlodipine: A calcium channel blocker, generally safe in diabetic patients and does not interfere with hypoglycemia awareness.

Conclusion

Due to its ability to mask the adrenergic symptoms of hypoglycemia and potentially worsen glycemic control, Propranolol is the antihypertensive agent that should be avoided in this diabetic patient with recurrent hypoglycemia.